Clinical Trial Update: An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia

View source ↗

Summary

An observational study assessing quality of life in dialysis patients with chronic renal anemia treated with epoetin beta (Neorecormon).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED